Haemonetics Corporation - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
HAE New York 3841 https://www.haemonetics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Haemonetics Corporation

Teleflex (TFX) Urolift Market Expansion Strong, Cost Woe Stays - Mar 30th, 2023 1:15 pm
Thermo Fisher (TMO) Partners With ArsenalBio for Cancer R&D - Mar 30th, 2023 11:45 am
Masimo (MASI) Unveils Freedom Smartwatch With Privacy Switch - Mar 29th, 2023 12:14 pm
Insulet (PODD) Benefits From Omnipod 5 Launch, Expansion - Mar 28th, 2023 3:24 pm
Thermo Fisher (TMO) Opens New Cell Therapy Facility at UCSF - Mar 28th, 2023 11:14 am
Walgreens Boots (WBA) Benefits From Innovation Amid Margin Woe - Mar 27th, 2023 2:40 pm
Abbott's (ABT) CardioMEMS Favors Heart Failure Management - Mar 27th, 2023 11:37 am
HAE vs. SYK: Which Stock Should Value Investors Buy Now? - Mar 24th, 2023 3:40 pm
Globus Medical (GMED) to Gain From NUVA Deal Amid Rising Costs - Mar 24th, 2023 2:55 pm
Smith & Nephew's (SNN) CIT Technology Favored by New Study - Mar 24th, 2023 11:49 am
Syneos Health (SYNH) Partners With KX for Data-Driven Insights - Mar 23rd, 2023 12:28 pm
Henry Schein (HSIC) Bolsters Dental Practices With AI Tools - Mar 22nd, 2023 11:40 am
Quest Diagnostics (DGX) Acquires Northern Light Laboratory - Mar 21st, 2023 2:43 pm
NuVasive's (NUVA) Precice System Cleared for Pediatric Patients - Mar 21st, 2023 11:40 am
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes - Mar 20th, 2023 1:51 pm
Quest Diagnostics (DGX) Updates Its Strategic Focus, LT Growth - Mar 20th, 2023 1:45 pm
Here's Why You Should Retain Boston Scientific (BSX) Now - Mar 20th, 2023 1:07 pm
Bruker (BRKR) Receives 1.2 GHz NMR System Orders From the UK - Mar 20th, 2023 12:17 pm
Investors in Haemonetics (NYSE:HAE) have made a favorable return of 38% over the past year - Mar 20th, 2023 10:53 am
Tandem Diabetes (TNDM) Releases Favorable Data on t:slim X2 - Mar 17th, 2023 7:03 pm